Blood Coagulation Disorders, Inherited - 23 Studies Found

Completed : Alphanate in Immune Tolerance Induction Therapy
: Hemophilia A, Congenital
: 2017-03-23
: Biological: Alphanate Daily intravenous infusion of Alphanate 100 IU/kg/day
Not yet recruiting : A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment
: Hemophilia A
: 2017-03-10
: Biological: rFVIIIFc rFVIIIFc 200 IU/kg/day in ITI Period and 50 or 100 IU/kg (adjusted according to Inv
Completed : Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency
: Factor VII Deficiency
: 2017-03-04
:
  • Biological: Eptacog alfa, biosimilar and reference medicinal product Novosev
Not yet recruiting : Dose-Ranging Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 in Subjects With Severe Hemophilia A
: Hemophilia A
: 2017-02-15
: Biological: SB-525 Single dose of investigational product SB-525
Completed : Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
:
  • Haemophilia
  • Developing Countries

: 2017-02-13
:
  • Other: Education Education of

Active, not recruiting : Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe
:
  • Factor VIII Deficiency, Congenital
  • Factor 8 Deficiency, Congenital
  • Hemophilia A
  • Hemophilia
  • Factor VIII Deficiency

: 2016-12-22
: Drug: Octocog Alfa Other Names:
  • Advate®
  • Human Factor VIII
Not yet recruiting : Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography
: Hemophilia A With Inhibitors
: 2016-12-19
: Other: Thromboelastography-Guided Treatment Regimen The thromboelastograph (TEG) will be used to determi
Not yet recruiting : Gene Therapy for Haemophilia A.
:
: 2025-08-02
<<< Previous | Next >>>